- Home
- INCR vs EPIX Comparison
INCR vs EPIX Comparison
Compare INCR & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- EPIX
- Stock Information
- Founded
- INCR 1994
- EPIX 2009
- Country
- INCR Israel
- EPIX Canada
- Employees
- INCR N/A
- EPIX N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- INCR Health Care
- EPIX Health Care
- Exchange
- INCR Nasdaq
- EPIX Nasdaq
- Market Cap
- INCR 84.5M
- EPIX 75.9M
- IPO Year
- INCR N/A
- EPIX N/A
- Fundamental
- Price
- INCR $1.55
- EPIX $1.86
- Analyst Decision
- INCR
- EPIX Hold
- Analyst Count
- INCR 0
- EPIX 3
- Target Price
- INCR N/A
- EPIX $2.00
- AVG Volume (30 Days)
- INCR 24.7K
- EPIX 224.6K
- Earning Date
- INCR 08-15-2025
- EPIX 08-04-2025
- Dividend Yield
- INCR N/A
- EPIX N/A
- EPS Growth
- INCR N/A
- EPIX N/A
- EPS
- INCR N/A
- EPIX N/A
- Revenue
- INCR $65,575,323.00
- EPIX N/A
- Revenue This Year
- INCR $69.54
- EPIX N/A
- Revenue Next Year
- INCR $41.75
- EPIX N/A
- P/E Ratio
- INCR N/A
- EPIX N/A
- Revenue Growth
- INCR N/A
- EPIX N/A
- 52 Week Low
- INCR $1.17
- EPIX $1.40
- 52 Week High
- INCR $2.62
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- INCR 53.16
- EPIX 51.31
- Support Level
- INCR $1.48
- EPIX $1.68
- Resistance Level
- INCR $1.64
- EPIX $1.75
- Average True Range (ATR)
- INCR 0.05
- EPIX 0.04
- MACD
- INCR 0.01
- EPIX 0.00
- Stochastic Oscillator
- INCR 57.14
- EPIX 62.50
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.